-
Mashup Score: 4The OncFive: Top Oncology Articles for the Week of 12/18 - 15 hour(s) ago
Fixed-duration acalabrutinib combination improves PFS in CLL, imlunestrant ± abemaciclib boosts PFS in ESR1-mutated ER+ breast cancer, and more.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4The OncFive: Top Oncology Articles for the Week of 12/18 - 4 day(s) ago
Fixed-duration acalabrutinib combination improves PFS in CLL, imlunestrant ± abemaciclib boosts PFS in ESR1-mutated ER+ breast cancer, and more.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Too busy to stay on top of the top #oncology articles from the past week? We have you covered. Behold, the #OncFive 5️⃣: https://t.co/2xiSjp51lE @ASH_Hematology @SABCSSanAntonio #leusm #mmsm #bcsm #lcsm #SABCS24 #ASH24 #medtwitter #oncology https://t.co/2xiSjp51lE https://t.co/B8qhdqLcWS
-
-
Mashup Score: 3The OncFive: Top Oncology Articles for the Week of 12/18 - 24 day(s) ago
Fixed-duration acalabrutinib combination improves PFS in CLL, imlunestrant ± abemaciclib boosts PFS in ESR1-mutated ER+ breast cancer, and more.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Too busy to stay on top of the top #oncology articles from the past week? We have you covered. Behold, the #OncFive 5️⃣: https://t.co/2xiSjp51lE @ASH_Hematology @SABCSSanAntonio #leusm #mmsm #bcsm #lcsm #SABCS24 #ASH24 #medtwitter #oncology https://t.co/2xiSjp51lE https://t.co/B8qhdqLcWS
-
Too busy to stay on top of the top #oncology articles from the past week? We have you covered. Behold, the #OncFive 5️⃣: https://t.co/2xiSjp51lE @ASH_Hematology @SABCSSanAntonio #leusm #mmsm #bcsm #lcsm #SABCS24 #ASH24 #medtwitter #oncology https://t.co/2xiSjp51lE https://t.co/B8qhdqLcWS